VAL401 – for the treatment of adenocarcinoma
Opportunity ContactMark Treharne, Head of Corporate DevelopmentLondon, United Kingdom ValiRx Website Pharmalicensing.com VAL401 is the reformulation of the anti-psychotic drug Risperidone in a lipid-based capsule which enables anti-cancer biology that is not